phase iii

Incyte Reports Additional Analyses of Symptomatic Improvement and Quality of Life with Ruxolitinib (INC424) in Patients with Myelofibrosis from the COMFORT-I Study

by Symptom Advice on June 14, 2011

The New England Journal of Medicine Publishes Pivotal Studies Showing Potential of New Investigational Treatment for Chronic Infection with Hepatitis C Virus Genotype 1

by Symptom Advice on April 14, 2011

immatics to Receive Support From Pfizer for its Pivotal Phase III Study (IMPRINT) With IMA901, a Therapeutic Vaccine for Advanced Renal Cell Cancer Patients

by Symptom Advice on April 12, 2011

Vertex: Stellar Data for Cystic Fibrosis Drug

by Symptom Advice on March 2, 2011

Eisai to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Therapy for Partial Seizures in Patients with Epilepsy

by Symptom Advice on February 12, 2011

Santarus Announces Positive Top-Line Results in E.U. Phase III Clinical Study Evaluating Budesonide MMX in Ulcerative Colitis

by Symptom Advice on December 6, 2010

Shire’s Vyvanse demonstrates efficacy in new trial

by Symptom Advice on August 22, 2010